Understanding the value of strategic formulation planning
Learn more about the importance of smart strategies in early OSD development. Pharma Ignite and Thermo Fisher Scientific take you inside the perils of trading long term success for fast wins in early formulation decision making. Discover why a long-range vision and the support of an experienced CDMO partner are critical to attaining regulatory and scalability success.
Read the blog to explore:
- Hidden risks of rushing to FIH
- Early decisions’ downstream impact on CMC readiness and future scale-up
- Leveraging CDMO partnerships to reduce the risk of formulation and regulatory setbacks
- Achieving better risk and time management with the right tools plus scientific and regulatory insight
- Key questions to ask a CDMO before OSD formulation
- Building for what comes next